Manus Bio Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
118
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$32.5M
- Investors
-
23
Manus Bio General Information
Description
Developer of an advanced fermentation technology designed to recreate plant processes in microorganisms to produce natural ingredients through fermentation. The company's technology helps in manufacturing complex and bioactive natural products such as flavors, fragrances, food ingredients, bio-pesticides, and pharmaceuticals, enabling businesses to make affordable and sustainable products.
Contact Information
Website
www.manusbio.comFormerly Known As
Manus Biosynthesis
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
- 43 Foundry Avenue
- Suite 230
- Waltham, MA 02453
- United States
+1 (706) 000-0000
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
- 43 Foundry Avenue
- Suite 230
- Waltham, MA 02453
- United States
+1 (706) 000-0000
Manus Bio Timeline
Manus Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 17. Later Stage VC | 14-May-2024 | $32.5M | 00000 | Completed | Generating Revenue | |
| 16. Grant | 31-Aug-2022 | 000 | 00000 | Completed | Generating Revenue | |
| 15. Debt - General | 07-Jun-2022 | 0000 | 00000 | Completed | Generating Revenue | |
| 14. Debt - General | 20-Aug-2021 | 0000 | 00000 | Completed | Generating Revenue | |
| 13. Later Stage VC (Series B) | 06-Nov-2020 | 0000 | 000.00 | 00000 | Completed | Generating Revenue |
| 12. Debt - PPP | 15-Apr-2020 | 00000 | 000.00 | Completed | Generating Revenue | |
| 11. Later Stage VC (Series A1) | 05-Jun-2018 | 00.00 | 000.00 | 0000 | Completed | Generating Revenue |
| 10. Grant | 11-Jan-2018 | 00000 | 000.00 | Completed | Generating Revenue | |
| 9. Grant | 01-Jan-2018 | $720K | $12.7M | Completed | Generating Revenue | |
| 8. Grant | 01-Jan-2018 | $100K | $12.7M | Completed | Generating Revenue |
Manus Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B3 | 000,000 | 00.000000 | 00 | 000.0 | 000.0 | 00 | 000.0 | 0.000 |
| Series B2 | 00,000 | 00.000000 | 00 | 000.00 | 000.00 | 00 | 000.00 | 0.000 |
| Series B1 | 000,000 | 00.000000 | 00 | 000.00 | 000.00 | 00 | 000.00 | 00.000 |
| Series A1 | 000,000 | 00.000000 | 00 | 000.00 | 000.00 | 00 | 000.00 | 00.000 |
| Series A | 000,000 | 00.000000 | 00 | 000.00 | 000.00 | 00 | 000.00 | 00.000 |
| Seed 2 | 616,765 | $0.001000 | 5% | $4.86 | $4.86 | 1x | $4.86 | 10.56% |
| Seed 1 | 88,951 | $0.001000 | 10% | $4.6 | $4.6 | 1x | $4.6 | 1.52% |
Manus Bio Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of an advanced fermentation technology designed to recreate plant processes in microorganisms to produce natur
Biotechnology
Waltham, MA
118
As of 2024
00000
0000000000 0
00000
000000
e velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cup
0000000000000
Bedford, MA
00
As of 0000
000000000 -
000000
bore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation
0000000000000
Lyngby, Denmark
00000
As of 0000
00000000
Add Comparison
Manus Bio Competitors (19)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Conagen | Corporate Backed or Acquired | Bedford, MA | 00 | 000000000 - | ||
| Novonesis | Corporation | Lyngby, Denmark | 00000 | 00000000 | ||
| Arzeda | Venture Capital-Backed | Seattle, WA | 00 | 0000 | 00000000000 | 0000 |
| Codexis | Formerly VC-backed | Redwood City, CA | 000 | 00000 | 000000000000 | 00000 |
| Perpetual Biotechnologies | Formerly Angel backed | Nicosia, Cyprus | 0 | 00000000000 |
Manus Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Manus Bio Patents
Manus Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4399320-A1 | Enzymes, host cells, and methods for biosynthesis of dammarenediol and derivatives | Pending | 09-Sep-2021 | 000000000 | |
| EP-4337768-A1 | Enzymes, host cells, and methods for production of rotundone and other terpenoids | Pending | 11-May-2021 | 00000000 | |
| US-20240254521-A1 | Enzymes, host cells, and methods for production of rotundone and other terpenoids | Pending | 11-May-2021 | 00000000 | |
| US-20240057595-A1 | Insect repellent compositions | Pending | 29-Dec-2020 | 000000000 | |
| AU-2021386386-A1 | Glycoside product biosynthesis and recovery | Pending | 24-Nov-2020 | C12N15/70 |
Manus Bio Executive Team (13)
| Name | Title | Board Seat |
|---|---|---|
| Ajikumar Parayil Ph.D | Co-Founder, Chief Executive Officer, President & Board Member | |
| Julio Calderon | Chief Financial Officer | |
| Christine Santos | Chief Technology Officer | |
| Brendan Naulty | President, Chief Revenue Officer, Advisor & Chief Commercial Officer | |
| Gregory Stephanopoulos Ph.D | Co-Founder & Board Member |
Manus Bio Board Members (13)
| Name | Representing | Role | Since |
|---|---|---|---|
| Alena Ivashenka | Self | Board Member | 000 0000 |
| Gregory Stephanopoulos Ph.D | Manus Bio | Co-Founder & Board Member | 000 0000 |
| Jean Nehme | Manus Bio | Chairman | 000 0000 |
| Jeanmarie Desmond | Self | Board Member | 000 0000 |
| Kittiphong Limsuwannarot | BBGI | Board Member | 000 0000 |
Manus Bio Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Manus Bio Investors (23)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Energy Impact Partners | Venture Capital | Minority | 000 0000 | 000000 0 |
| Abhijeet Birewar | Angel (individual) | Minority | 000 0000 | 000000 0 |
| Andrew Ervin | Angel (individual) | Minority | 000 0000 | 000000 0 |
| Andrew Rapkin | Angel (individual) | Minority | 000 0000 | 000000 0 |
| BBGI | Corporation | Minority | 000 0000 | 000000 0 |
Manus Bio Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| WIN Ingredients | 17-Nov-2020 | 00000 0000 | Food Products | 00000000 | |
| NutraSweet (Plant in Augusta, Georgia) | 29-Jun-2018 | Corporate Asset Purchase | Buildings and Property | 00000000 |
Manus Bio FAQs
-
When was Manus Bio founded?
Manus Bio was founded in 2011.
-
Who is the founder of Manus Bio?
Ajikumar Parayil Ph.D, Gregory Stephanopoulos Ph.D, and Christopher Pirie Ph.D are the founders of Manus Bio.
-
Who is the CEO of Manus Bio?
Ajikumar Parayil Ph.D is the CEO of Manus Bio.
-
Where is Manus Bio headquartered?
Manus Bio is headquartered in Waltham, MA.
-
What is the size of Manus Bio?
Manus Bio has 118 total employees.
-
What industry is Manus Bio in?
Manus Bio’s primary industry is Biotechnology.
-
Is Manus Bio a private or public company?
Manus Bio is a Private company.
-
What is Manus Bio’s current revenue?
The current revenue for Manus Bio is 00000.
-
How much funding has Manus Bio raised over time?
Manus Bio has raised $170M.
-
Who are Manus Bio’s investors?
Energy Impact Partners, Abhijeet Birewar, Andrew Ervin, Andrew Rapkin, and BBGI are 5 of 23 investors who have invested in Manus Bio.
-
Who are Manus Bio’s competitors?
Conagen, Novonesis, Arzeda, Codexis, and Perpetual Biotechnologies are some of the 19 competitors of Manus Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
